Liver cancer breakthrough – Vitamin C preferentially kills liver cancer stem cell

Share This Post

At the end of 2015, science research claimed that high doses of vitamin C (about the equivalent of 300 oranges) can effectively kill colon cancer cells that carry a common carcinogenic mutation (KRAS and BRAF).

In March 2017, “Cancer Cell” magazine confirmed that it is safe to regularly inject 800-1000 times the recommended daily dose of vitamin C in patients with brain and lung cancer, and it can change iron metabolism and cause specific DNA damage in cancer cells. Cause cell death and achieve effective treatment of cancer.

In August of the same year, it was demonstrated in the journals “Cell” and “Nature” that vitamin C can control the occurrence of hematological tumors and reverse leukemia by activating the activity of an epigenetic modification enzyme (TET2).

At the beginning of 2018, in the “Npj-Precision Medical Oncology” sub-journal of Nature, the research team of Academician Wang Hongyang from the Eastern Hepatobiliary Surgery Hospital of the Naval Military Medical University brought exciting research progress- vitamin C “priority” killing Cancer stem cells of liver cancer and improve the prognosis of patients .

However, only the high dose of vitamin C in the blood obtained through “intravenous administration” has been researched and confirmed to have an anti-cancer effect, and it is not achieved by “eating” oranges or vitamin C tablets. When we get too much vitamin C from the diet, the body will excrete excess vitamin C through the urine. Seeing this, did you silently put down the orange that was hard to put in your mouth? So please don’t blindly add vitamin C, because it is useless and wastes money.

Although research has confirmed that injecting vitamin C can help fight liver cancer tumors, do not blindly supplement vitamin C, do not need to eat too many fruits rich in vitamin C, and do n’t use the results of the above research stage as a basis, Note: “Vitamin C should listen to the clinician’s advice.

Website |  + posts

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Vimseltinib is approved by the USFDA for symptomatic tenosynovial giant cell tumor
Cancer

Vimseltinib is approved by the USFDA for symptomatic tenosynovial giant cell tumor

The FDA approved vimseltinib for symptomatic tenosynovial giant cell tumor (TGCT) in patients who cannot be treated with surgery. The oral CSF1R inhibitor blocks tumor growth and alleviates symptoms, providing a surgery-free way to control TGCT. The approval is based on clinical trial evidence of substantial tumor shrinkage and symptom relief. The approval is a significant step forward in TGCT treatment, enhancing the quality of life for these patients.

Brentuximab vedotin with lenalidomide and rituximab is approved by the USFDA for relapsed or refractory large B-cell lymphoma
Blood cancer

Brentuximab vedotin with lenalidomide and rituximab is approved by the USFDA for relapsed or refractory large B-cell lymphoma

The FDA approved brentuximab vedotin in combination with lenalidomide and rituximab to treat relapsed or refractory large B-cell lymphoma (LBCL). The combination represents a new option for treatment after failure of initial therapies. The approval follows the presentation of data from clinical trials showing that this combination improved patient outcomes. This combination is a new strategy in the management of LBCL and provides a greater number of available treatments for those with few choices.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

CancerFax is the most trusted online platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies.

Send your medical reports and get a free analysis.

🌟 Join us in the fight against cancer! 🌟

Привет,

CancerFax — это самая надежная онлайн-платформа, призванная предоставить людям, столкнувшимся с раком на поздних стадиях, доступ к революционным клеточным методам лечения.

Отправьте свои медицинские заключения и получите бесплатный анализ.

🌟 Присоединяйтесь к нам в борьбе с раком! 🌟